Company news

Assertio Holdings, Inc. news in 2023

Assertio Holdings, Inc.'s news releases, calls and decks from 2023, newest first.

View company

Assertio Holdings, Inc. Appoints Sravan Emany to Its Board of Directors

November 13, 2023

Assertio Reports Third Quarter 2023 Financial Results

November 7, 2023

Assertio Holdings, Inc. to Release Third Quarter 2023 Financial Results on November 8, 2023

November 1, 2023

Assertio Reports Second Quarter 2023 Financial Results, Closes Spectrum Acquisition

August 2, 2023

Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals Transaction

July 30, 2023

Assertio Holdings, Inc. Announces Favorable Vote on Proposed Acquisition of Spectrum Pharmaceuticals

July 26, 2023

Assertio Holdings, Inc. to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023

July 23, 2023

Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “FOR” Proposed Transaction with Assertio Holdings, Inc.

July 19, 2023

Assertio Holdings Joins Russell 3000® Index

June 25, 2023

Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update

May 8, 2023

Assertio Reports First Quarter 2023 Financial Results, Raises Full Year 2023 Outlook

May 8, 2023

Assertio Holdings, Inc. Updates First Quarter 2023 Financial Results Call Time to Tuesday, May 9, 2023 at 11: 30 am Eastern Time

May 4, 2023

Assertio Holdings, Inc. to Report First Quarter 2023 Financial Results on Tuesday, May 9, 2023

April 26, 2023

Assertio Holdings, Inc. to Acquire Spectrum Pharmaceuticals, Inc. in All Stock and CVR Transaction

April 24, 2023

Assertio Provides Educational Grant for New Lennox-Gastaut Syndrome (LGS) Foundation Treatments Kits

April 23, 2023

Assertio Reports Fourth Quarter and Full Year 2022 Financial Results

March 7, 2023

Assertio Appoints Dr. Howard Franklin as Senior Vice President, Medical

March 5, 2023

Assertio Announces Exchange Offer of $30 Million of its Currently Outstanding 6.50% Convertible Senior Notes Due 2027

February 22, 2023

Assertio Holdings, Inc. Announces Preliminary Fourth Quarter and Full Year 2022 Results

February 20, 2023

Assertio to Participate in the 2023 Winter Wonderland Best Ideas Conference

February 15, 2023

Assertio to Participate in the 2023 SVB Securities Global Biopharma Conference

February 7, 2023

Assertio Announces Partnership with the Lennox-Gastaut Syndrome (LGS) Foundation

January 16, 2023

Assertio Holdings, Inc. Announces FDA Orange Book Listing for New Sympazan® Oral Film Patent

January 8, 2023

Calls in 2023

Decks in 2023